CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: antidiarrhoeal drug
Accession: CHEBI:55323
browse the term
Definition: Any drug found useful in the symptomatic treatment of diarrhoea.
Synonyms: related_synonym: antidiarrheal; antidiarrheal agent; antidiarrheal agents; antidiarrheal drug; antidiarrheal drugs; antidiarrheals; antidiarrhoeal; antidiarrhoeal agent; antidiarrhoeal agents; antidiarrhoeal drugs; antidiarrhoeals; antiperistaltic; antiperistaltic agent; antiperistaltic agents; antiperistaltic drug; antiperistaltic drugs; antiperistaltics
G
Tp53
tumor protein p53
affects activity
ISO
Diphenoxylate affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
F11
coagulation factor XI
decreases activity
ISO
Kaolin results in decreased activity of F11 protein
CTD
PMID:6604052
NCBI chr16:46,987,988...47,009,015
Ensembl chr16:46,986,107...47,008,437
G
F12
coagulation factor XII
increases activity
ISO
Kaolin results in increased activity of F12 protein
CTD
PMID:6343536
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
G
Abcb11
ATP binding cassette subfamily B member 11
decreases expression
ISO
Loperamide results in decreased expression of ABCB11 mRNA
CTD
PMID:35926757
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
affects binding affects response to substance increases transport multiple interactions decreases expression
ISO
Loperamide binds to ABCB1 protein ABCB1A protein affects the susceptibility to Loperamide ABCB1 protein results in increased transport of Loperamide Loperamide inhibits the reaction [Doxorubicin results in increased expression of ABCB1 mRNA] Loperamide results in decreased expression of ABCB1 mRNA
CTD
PMID:15502009 PMID:23976943 PMID:34719826
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
affects response to substance
ISO
ABCB1B protein affects the susceptibility to Loperamide
CTD
PMID:15502009
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression
ISO
Loperamide results in decreased expression of ABCC2 mRNA
CTD
PMID:35926757
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcg5
ATP binding cassette subfamily G member 5
decreases expression
ISO
Loperamide results in decreased expression of ABCG5 mRNA
CTD
PMID:35926757
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Ano1
anoctamin 1
decreases expression multiple interactions
ISO
Loperamide results in decreased expression of ANO1 mRNA; Loperamide results in decreased expression of ANO1 protein Foeniculum vulgare fruit inhibits the reaction [Loperamide results in decreased expression of ANO1 mRNA]; Foeniculum vulgare fruit inhibits the reaction [Loperamide results in decreased expression of ANO1 protein]; mosapride inhibits the reaction [Loperamide results in decreased expression of ANO1 mRNA]; mosapride inhibits the reaction [Loperamide results in decreased expression of ANO1 protein]
CTD
PMID:37375548
NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:199,751,439...199,900,069
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO
Loperamide promotes the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] Loperamide results in decreased expression of BCL2 mRNA
CTD
PMID:34719826
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cat
catalase
decreases expression
EXP
Loperamide results in decreased expression of CAT protein
CTD
PMID:30597669
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
Loperamide results in increased expression of CDKN1A mRNA Loperamide promotes the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]
CTD
PMID:34719826
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Ces2h
carboxylesterase 2H
decreases activity multiple interactions
ISO
Loperamide results in decreased activity of CES2 protein [Loperamide results in decreased activity of CES2 protein] which results in increased susceptibility to Bisphenol A-Glycidyl Methacrylate
CTD
PMID:15687373 PMID:21951919 PMID:28647665
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Ch25h
cholesterol 25-hydroxylase
increases expression
ISO
Loperamide results in increased expression of CH25H mRNA
CTD
PMID:35926757
NCBI chr 1:232,014,877...232,016,195
Ensembl chr 1:232,014,880...232,016,195
G
Ckb
creatine kinase B
multiple interactions
EXP
Loperamide results in increased secretion of [CKM protein binds to CKB protein]
CTD
PMID:30597669
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
G
Ckm
creatine kinase, M-type
multiple interactions
EXP
Loperamide results in increased secretion of [CKM protein binds to CKB protein]
CTD
PMID:30597669
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
[Axitinib results in decreased activity of CYP3A4 protein] which results in decreased metabolism of Loperamide
CTD
PMID:31299239
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
increases expression
ISO
Loperamide results in increased expression of CYP7A1 mRNA
CTD
PMID:35926757
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Fabp6
fatty acid binding protein 6
increases expression
ISO
Loperamide results in increased expression of FABP6 mRNA
CTD
PMID:35926757
NCBI chr10:28,063,603...28,068,276
Ensembl chr10:28,063,603...28,068,282
G
Fdps
farnesyl diphosphate synthase
increases expression
ISO
Loperamide results in increased expression of FDPS mRNA
CTD
PMID:35926757
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Got1
glutamic-oxaloacetic transaminase 1
increases secretion
EXP
Loperamide results in increased secretion of GOT1 protein
CTD
PMID:30597669
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
Loperamide results in increased expression of HMGCR mRNA
CTD
PMID:35926757
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Htr4
5-hydroxytryptamine receptor 4
multiple interactions decreases expression
ISO
Foeniculum vulgare fruit inhibits the reaction [Loperamide results in decreased expression of HTR4 mRNA]; mosapride inhibits the reaction [Loperamide results in decreased expression of HTR4 mRNA]
CTD
PMID:37375548
NCBI chr18:55,765,981...55,949,921
Ensembl chr18:55,766,725...55,949,321
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
ISO
Loperamide results in increased expression of IDI1 mRNA
CTD
PMID:35926757
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Il2
interleukin 2
decreases expression
ISO
Loperamide results in decreased expression of IL2 mRNA
CTD
PMID:23965172
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
increases expression
ISO
Loperamide results in increased expression of IL4 mRNA
CTD
PMID:23965172
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Lss
lanosterol synthase
increases expression
ISO
Loperamide results in increased expression of LSS mRNA
CTD
PMID:35926757
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
Loperamide results in increased phosphorylation of MAPK1 protein
CTD
PMID:23965172
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
Loperamide results in increased phosphorylation of MAPK3 protein
CTD
PMID:23965172
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
decreases expression multiple interactions
ISO
Loperamide results in decreased expression of MAPK8 mRNA Loperamide promotes the reaction [Doxorubicin results in decreased expression of MAPK8 mRNA]
CTD
PMID:34719826
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions decreases expression
ISO
Loperamide promotes the reaction [Doxorubicin results in decreased expression of MTOR mRNA] Loperamide results in decreased expression of MTOR mRNA
CTD
PMID:34719826
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Mvk
mevalonate kinase
increases expression
ISO
Loperamide results in increased expression of MVK mRNA
CTD
PMID:35926757
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
G
Mylk
myosin light chain kinase
decreases expression multiple interactions
ISO
Loperamide results in decreased expression of MYLK mRNA Foeniculum vulgare fruit inhibits the reaction [Loperamide results in decreased expression of MYLK mRNA]; mosapride inhibits the reaction [Loperamide results in decreased expression of MYLK mRNA]
CTD
PMID:37375548
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
G
Nfkbia
NFKB inhibitor alpha
increases expression
ISO
Loperamide results in increased expression of NFKBIA protein
CTD
PMID:22258905
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos1
nitric oxide synthase 1
multiple interactions decreases expression
ISO
Foeniculum vulgare fruit inhibits the reaction [Loperamide results in decreased expression of NOS1 protein]; mosapride inhibits the reaction [Loperamide results in decreased expression of NOS1 protein]
CTD
PMID:37375548
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
[Loperamide co-treated with Rifampin] results in increased activity of NR1I2 protein
CTD
PMID:20869355
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
[Loperamide co-treated with PK 11195] results in decreased activity of NR1I3 protein alternative form; Loperamide binds to and results in decreased activity of NR1I3 protein alternative form
CTD
PMID:20869355
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Oprd1
opioid receptor, delta 1
affects response to substance
ISO
OPRD1 protein affects the susceptibility to Loperamide
CTD
PMID:25261794
NCBI chr 5:144,306,188...144,340,960
Ensembl chr 5:144,306,188...144,340,960
G
Pld2
phospholipase D2
increases activity
ISO
Loperamide results in increased activity of PLD2 protein
CTD
PMID:23965172
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
G
Ryr3
ryanodine receptor 3
decreases expression multiple interactions
ISO
Loperamide results in decreased expression of RYR3 mRNA Foeniculum vulgare fruit inhibits the reaction [Loperamide results in decreased expression of RYR3 mRNA]; mosapride inhibits the reaction [Loperamide results in decreased expression of RYR3 mRNA]
CTD
PMID:37375548
NCBI chr 3:99,431,755...99,979,125
Ensembl chr 3:99,432,505...99,704,961
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Loperamide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc51a
solute carrier family 51 member A
increases expression
ISO
Loperamide results in increased expression of SLC51A mRNA
CTD
PMID:35926757
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Sqle
squalene epoxidase
increases expression
ISO
Loperamide results in increased expression of SQLE mRNA
CTD
PMID:35926757
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Tnni3
troponin I3, cardiac type
increases secretion
EXP
Loperamide results in increased secretion of TNNI3 protein
CTD
PMID:30597669
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
G
Trpm7
transient receptor potential cation channel, subfamily M, member 7
multiple interactions decreases expression
ISO
Foeniculum vulgare fruit inhibits the reaction [Loperamide results in decreased expression of TRPM7 protein]
CTD
PMID:37375548
NCBI chr 3:114,046,258...114,134,799
Ensembl chr 3:114,046,258...114,135,190
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions decreases response to substance decreases activity
ISO
[tectochrysin results in decreased activity of ABCB1 protein] which results in decreased export of calcein AM; tectochrysin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Docetaxel]; tectochrysin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Paclitaxel]; tectochrysin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine] ABCB1 protein results in decreased susceptibility to tectochrysin
CTD
PMID:37259354
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcg2
ATP binding cassette subfamily G member 2
decreases activity
ISO
tectochrysin results in decreased activity of ABCG2 protein
CTD
PMID:15930306
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all